Cosma A - Search Results

1

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

Mamani-Matsuda M, Cosma A, Weller S, Faili A, Staib C, Garçon L, Hermine O, Beyne-Rauzy O, Fieschi C, Pers JO, Arakelyan N, Varet B, Sauvanet A, Berger A, Paye F, Andrieu JM, Michel M, Godeau B, Buffet P, Reynaud CA, Weill JC. Mamani-Matsuda M, et al. Among authors: cosma a. Blood. 2008 May 1;111(9):4653-9. doi: 10.1182/blood-2007-11-123844. Epub 2008 Mar 3. Blood. 2008. PMID: 18316630 Free article.

2

Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting.

Chappert P, Huetz F, Espinasse MA, Chatonnet F, Pannetier L, Da Silva L, Goetz C, Mégret J, Sokal A, Crickx E, Nemazanyy I, Jung V, Guerrera C, Storck S, Mahévas M, Cosma A, Revy P, Fest T, Reynaud CA, Weill JC. Chappert P, et al. Among authors: cosma a. Immunity. 2022 Oct 11;55(10):1872-1890.e9. doi: 10.1016/j.immuni.2022.08.019. Epub 2022 Sep 20. Immunity. 2022. PMID: 36130603 Free PMC article.

3

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

Cosma A, Nagaraj R, Staib C, Diemer C, Wopfner F, Schätzl H, Busch DH, Sutter G, Goebel FD, Erfle V. Cosma A, et al. AIDS Res Hum Retroviruses. 2007 Jun;23(6):782-93. doi: 10.1089/aid.2006.0226. AIDS Res Hum Retroviruses. 2007. PMID: 17604541 Clinical Trial.

4

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

Cosma A, Bühler S, Nagaraj R, Staib C, Hammarin AL, Wahren B, Goebel FD, Erfle V, Sutter G. Cosma A, et al. Clin Diagn Lab Immunol. 2004 Mar;11(2):406-10. doi: 10.1128/cdli.11.2.406-410.2004. Clin Diagn Lab Immunol. 2004. PMID: 15013995 Free PMC article.

5

Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Bruel T, Hamimi C, Dereuddre-Bosquet N, Cosma A, Shin SY, Corneau A, Versmisse P, Karlsson I, Malleret B, Targat B, Barré-Sinoussi F, Le Grand R, Pancino G, Sáez-Cirión A, Vaslin B. Bruel T, et al. Among authors: cosma a. J Virol. 2015 Apr;89(7):3542-56. doi: 10.1128/JVI.03723-14. Epub 2015 Jan 14. J Virol. 2015. PMID: 25589645 Free PMC article.

6

Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection.

Damouche A, Lazure T, Avettand-Fènoël V, Huot N, Dejucq-Rainsford N, Satie AP, Mélard A, David L, Gommet C, Ghosn J, Noel N, Pourcher G, Martinez V, Benoist S, Béréziat V, Cosma A, Favier B, Vaslin B, Rouzioux C, Capeau J, Müller-Trutwin M, Dereuddre-Bosquet N, Le Grand R, Lambotte O, Bourgeois C. Damouche A, et al. Among authors: cosma a. PLoS Pathog. 2015 Sep 24;11(9):e1005153. doi: 10.1371/journal.ppat.1005153. eCollection 2015 Sep. PLoS Pathog. 2015. PMID: 26402858 Free PMC article.

7

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.

Kutscher S, Allgayer S, Dembek CJ, Bogner JR, Protzer U, Goebel FD, Erfle V, Cosma A. Kutscher S, et al. Among authors: cosma a. Gene Ther. 2010 Nov;17(11):1372-83. doi: 10.1038/gt.2010.90. Epub 2010 Jun 10. Gene Ther. 2010. PMID: 20535218

8

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.

Cosma A, Nagaraj R, Bühler S, Hinkula J, Busch DH, Sutter G, Goebel FD, Erfle V. Cosma A, et al. Vaccine. 2003 Dec 8;22(1):21-9. doi: 10.1016/s0264-410x(03)00538-3. Vaccine. 2003. PMID: 14604567 Clinical Trial.

9

Therapeutic vaccination reduces HIV sequence variability.

Hoffmann D, Seebach J, Cosma A, Goebel FD, Strimmer K, Schätzl HM, Erfle V. Hoffmann D, et al. Among authors: cosma a. FASEB J. 2008 Feb;22(2):437-44. doi: 10.1096/fj.06-7975com. Epub 2007 Oct 10. FASEB J. 2008. PMID: 17932027

10

Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.

Hultström AL, Bratt G, Cosma A, Erfle V, Wahren B, Carbone E. Hultström AL, et al. Among authors: cosma a. Immunol Lett. 2004 Feb 15;91(2-3):155-8. doi: 10.1016/j.imlet.2003.11.012. Immunol Lett. 2004. PMID: 15019284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page